Biomea Fusion, Inc.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
BMEA$0.60+5.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
(in thousands)
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Cash flows from operating activities | |||
| Net loss | $(138,426) | $(117,255) | $(81,828) |
| Adjustments to reconcile net loss to net cash used in operating activities | |||
| Depreciation expense | 1,748 | 1,515 | 691 |
| Non-cash operating lease expense | 2,838 | 2,686 | 571 |
| Stock-based compensation expense | 19,094 | 14,131 | 10,336 |
| Net amortization of premiums and accretion of discounts on investments | — | 1 | 144 |
| Changes in operating assets and liabilities: | — | ||
| Prepaid expenses and other current assets | (7,738) | 2,478 | (1,725) |
| Other assets | 4,884 | (2,358) | (1,915) |
| Accounts payable | 6,088 | 2,562 | 2,960 |
| Accrued expenses and other current liabilities | (6,881) | 1,886 | 8,914 |
| Operating lease liabilities | (1,501) | (2,238) | (565) |
| Net cash used in operating activities | (119,894) | (96,592) | (62,417) |
| Cash flows from investing activities | |||
| Purchase of property and equipment | (362) | (3,370) | (1,030) |
| Maturities of investments | — | 1,150 | 28,371 |
| Net cash (used in) provided by investing activities | (362) | (2,220) | 27,341 |
| Cash flows from financing activities | |||
| Proceeds from issuance of common stock, net of offering costs | — | 161,803 | — |
| Proceeds from stock options exercised and purchases under the employee stock purchase plan | 1,668 | 1,995 | 1,239 |
| Net cash provided by financing activities | 1,668 | 163,798 | 1,239 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | (118,588) | 64,986 | (33,837) |
| Cash, cash equivalents, and restricted cash at the beginning of the period | 177,236 | 112,250 | 146,087 |
| Cash, cash equivalents, and restricted cash at the end of the period | $58,648 | $177,236 | $112,250 |
| Non-cash financing and investing activities: | |||
| Acquisition of operating lease right-of-use assets | $— | $5,971 | $— |
| Acquisition of property and equipment in accounts payable and accrued liabilities | $7 | $— | $2,537 |
| Remeasurement of operating lease right-of-use assets and lease liability | $— | $5,668 | — |
| Reconciliation of cash, cash equivalents and restricted cash: | |||
| Cash and cash equivalents | $58,279 | $176,866 | $111,899 |
| Restricted cash | 369 | 370 | 351 |
| Total cash, cash equivalents and restricted cash | $58,648 | $177,236 | $112,250 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.